Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Christopher Yea > Profile

Christopher Yea

Affiliations

  • Chief Development Officer at Kalvista Pharmaceuticals Inc. (KALV), 2024-08-26
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Kalvista Pharmaceuticals Inc.
 KALV $12.40 1,916 85,676 2024-08-23 Filing
Kalvista Pharmaceuticals Inc.
 KALV $12.01 7,102 84,467 2024-08-19 Filing
Kalvista Pharmaceuticals Inc.
 KALV $11.76 11,610 80,074 2024-05-20 Filing
Kalvista Pharmaceuticals Inc.
 KALV $14.11 12,053 72,895 2024-02-20 Filing
Kalvista Pharmaceuticals Inc.
 KALV $15.01 39,886 66,160 2024-02-14 Filing